Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . EVEREST MEDICINES 云顶 新 耀 Everest Medicines Limited 雲頂 新 耀 有限公司 ( incorporated in the Cayman Islands with limited liability ) ( Stock Code : 1952 ) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026 The board of directors ( the “ Board " ) of Everest Medicines Limited ( the “ Company ” ) announces the unaudited interim results of the Company and its subsidiaries for the six months ended 30 June 2026. This announcement , containing the full text of the 2026 interim report of the Company , complies with the relevant requirements of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited ( the " Stock Exchange ” ) in relation to information accompanying preliminary announcements of interim results . These interim results have been reviewed by the Company's audit committee and the Company's auditors , Ernst & Young . Both the Chinese and English versions of this results announcement are available on the websites of the Company ( www.everestmedicines.com ) and the Stock Exchange ( www.hkexnews.hk ) . Printed versions of the Company's 2026 interim report will be delivered to shareholders of the Company who have chosen to receive printed versions and electronic versions will be available for viewing on the websites of the Company ( www.everestmedicines.com ) and the Stock Exchange ( www.hkexnews.hk ) by the end of September 2026 . By Order of the Board Everest Medicines Limited Yifang Wu Chairman and Executive Director Hong Kong , 18 August 2026 As at the date of this announcement , the Board comprises Mr. Yifang Wu as Chairman and Executive Director , Mr. Yongqing Luo and Mr. Ian Ying Woo as Executive Directors , Mr. Wei Fu , Mr. Xin Sun and Ms. Yue Wang as Non - executive Directors , and Ms. Hoi Yam Chui , Mr. Yifan Li and Mr. Shidong Jiang as Independent Non - executive Directors .